PT  - JOURNAL ARTICLE
AU  - Da Silva, J A P
AU  - Jacobs, J W G
AU  - Kirwan, J R
AU  - Boers, M
AU  - Saag, K G
AU  - Inês, L B S
AU  - de Koning, E J P
AU  - Buttgereit, F
AU  - Cutolo, M
AU  - Capell, H
AU  - Rau, R
AU  - Bijlsma, J W J
TI  - Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
AID  - 10.1136/ard.2005.038638
DP  - 2006 Mar 01
TA  - Annals of the Rheumatic Diseases
PG  - 285--293
VI  - 65
IP  - 3
4099  - http://ard.bmj.com/content/65/3/285.short
4100  - http://ard.bmj.com/content/65/3/285.full
SO  - Ann Rheum Dis2006 Mar 01; 65
AB  - Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.